🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is for researchers to find ways of detecting panc...
Status
Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2024-03-04
Trial ID
NCT06305728
Treatments Being Tested
Imaging of proinflammatory activated microglia by Purine 2X7 (P2X7) recepto...
Status
Active Not Recruiting
Location
Kepler University Hospital
Start Date
2024-03-01
Trial ID
NCT05753995
Treatments Being Tested
The purpose of this study is to assess the whole-body biodistribution and t...
Status
Terminated
Location
UMC Gronningen Oncologie
Start Date
2022-11-21
Trial ID
NCT05638334
Treatments Being Tested
This phase III trial compares the effect of adding immunotherapy (brentuxim...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2023-05-11
Trial ID
NCT05675410
Treatments Being Tested
This phase I trial studies how well zirconium (Zr)-89 crefmirlimab berdoxam...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-12-05
Trial ID
NCT06650163
This study is researching an experimental drug called 89Zr-DFO-REGN5054 and...
Status
Recruiting
Location
UMC Groningen
Start Date
2023-02-07
Trial ID
NCT05259709
Treatments Being Tested
This phase II trial tests the impact of biomarkers in predicting initial tr...
Status
Recruiting
Location
CTCA at Western Regional Medical Center
Start Date
2026-04-08
Trial ID
NCT07288034
The main purpose of this study is to investigate the utility of the new inv...
Status
Withdrawn
Location
Investigational Site - Duarte
Start Date
2019-08
Trial ID
NCT04955262
Treatments Being Tested
Human epidermal growth factor receptor 3 (HER3) expression is seen across a...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-03-19
Trial ID
NCT02345174
Treatments Being Tested
This phase III trial studies how well combination chemotherapy, bevacizumab...
Status
Active Not Recruiting
Location
Kingman Regional Medical Center
Start Date
2018-01-19
Trial ID
NCT02997228